Answers are grounded in this paper and cite their sources.
AKR/J, SWR/J, P/J, C57BL/6J, and GR mice were given injections once a week for 20 weeks with 15 mg 1,2-dimethylhydrazine (DMH)/kg body weight. Colorectal tumors occurred in 83% of the SWR/J mice, 80% of the P/J mice, and 48% of the C57BL/6J mice that survived 22 or more weeks after the first injection; none occurred in strain AKR/J. Most of these tumors were adenomas and well-differentiated adenocarcinomas. The incidence of anal squamous cell carcinomas was nearly 100% (20/21) in GR mice; none of the C57BL/6J mice developed this type of tumor. Leukemias were common in AKR/J mice, whereas SWR/J mice developed leukemias and pulmonary adenomas in addition to the colorectal tumors. Multiple tumors of diverse types were also common in P/J mice. These results suggested that the host genotype or strain of mouse is crucial in determining the differential response to DMH-induced carcinogenesis.
No takes yet. Share an insight, caveat, or question.
Diwan et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: